Zdrowie i gospodarka · 26/04/2024

Promoting Effective Drug Development: Identifying Opportunities and Priorities for the FDA's Office of Clinical Pharmacology; Request for Comments

The Food and Drug Administration (FDA) is seeking public input on policy topics to prioritize in drug development, with a focus on the Office of Clinical Pharmacology (OCP) within the Center for Drug Evaluation and Research (CDER).